Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Lipocine Inc (NQ: LPCN )

1.120 USD -0.030 (-2.61%)
Streaming Delayed Price Updated: 3:24 PM EDT, Sep 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 217,452
Open 1.130
Bid (Size) 1.120 (42)
Ask (Size) 1.130 (49)
Prev. Close 1.150
Today's Range 1.113 - 1.160
52wk Range 1.090 - 2.420
Shares Outstanding 88,290,650
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lipocine to Present at The H.C. Wainwright 23rd Annual Global Investment Conference
Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will present at the H.C. Wainwright 23rd Annual... 
From PR Newswire
Top Reddit Penny Stocks to Watch in September 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed

Performance

YTD
-21.68%
-21.68%
1 Month
-18.25%
-18.25%
3 Month
-16.42%
-16.42%
6 Month
-41.36%
-41.36%
1 Year
-22.76%
-22.76%

More News

Read More
Lipocine's LPCN 1144 Met Non-Alcoholic Steatohepatitis ("NASH") Resolution Regulatory Endpoint in Phase 2 LiFT Study
From PR Newswire
Top Penny Stocks Analysts Say To Buy, Targets Up To 200% Right Now
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2021
From PR Newswire
Clarus Therapeutics Announces Comprehensive Settlement of Patent Litigation With Lipocine
From GlobeNewswire News Releases
Lipocine Announces Settlement With Clarus Therapeutics
From PR Newswire
Lipocine To Present At The Ladenburg Thalmann Healthcare Conference
From PR Newswire
Lipocine Announces Presentations at The International Liver Congress™ 2021 Digital Event
From PR Newswire
Lipocine To Present At The Raymond James Human Health Innovation Conference
From PR Newswire
Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial
Tags Long Ideas News LPCN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]